| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/29/2006 | WO2006067416A1 Chemical processes and intermediates |
| 06/29/2006 | WO2006067330A1 Pharmaceutical compositions based on fluorinated sulphamides and sulphinimides |
| 06/29/2006 | WO2006067173A2 Antithrombotic dual inhibitors comprising a biotin residue |
| 06/29/2006 | WO2006066968A1 Pyridine compounds for the treatment of prostaglandin mediated diseases |
| 06/29/2006 | WO2006066896A2 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin |
| 06/29/2006 | WO2006066879A2 Compounds with kv4 ion channel activity |
| 06/29/2006 | WO2006066599A2 Mas related g protein coupled receptors as drug targets |
| 06/29/2006 | WO2006066334A1 Potassium channels in human heart |
| 06/29/2006 | WO2005118782A3 Methods of promoting cardiac cell proliferation |
| 06/29/2006 | US20060142582 Crystalline forms of pitavastatin calcium |
| 06/29/2006 | US20060142391 Ppargamma-activating pharmaceutical composition |
| 06/29/2006 | US20060142336 N-sulfonylpiperidines as metalloproteinase inhibitors (tace) |
| 06/29/2006 | US20060142314 2-substituted-4-(indazol-5-ylamino)-6,7-dimethoxyquinazoline compounds; use treating hypertension, atherosclerosis, restenosis, cerebral ischemia or vasospasm, neurodegeneration, spinal cord injury, cancer, thrombotic disorders, asthma, glaucoma, osteoporosis or erectile dysfunction |
| 06/29/2006 | US20060142313 2-substituted-4-(indazolamino)quinazoline compounds; use treating hypertension, atherosclerosis, restenosis, cerebral ischemia or vasospasm, neurodegeneration, spinal cord injury, cancer, thrombotic disorders, asthma, glaucoma, osteoporosis or erectile dysfunction |
| 06/29/2006 | US20060142309 8-Heteroaryl xanthine adenosine A2B receptor antagonists |
| 06/29/2006 | US20060142292 Water-soluble phenylpyridazine derivative and medicine containing the same |
| 06/29/2006 | US20060142281 Indolinone derivatives |
| 06/29/2006 | US20060142268 1,4,5,6-tetrahydroimidazo[4,5-d]benzazepine derivative or salt thereof |
| 06/29/2006 | US20060142267 [6-hydroxy-2-(2-hydroxy-benzyl)-benzo [b]thiophen-3-yl]-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-methanone; [6-hydroxy-2-(2-hydroxy-benzyl)-naphthalen-1-yl]-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-methanone; 6-(2-hydroxy-benzyl)-5-{hydroxy-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-methyl}-naphthalen-2-ol |
| 06/29/2006 | US20060142266 Compounds and their uses |
| 06/29/2006 | US20060142258 Estrogen replacement therapy |
| 06/29/2006 | US20060142254 Antipyretic preparation containing xylitol |
| 06/29/2006 | US20060142209 Glucopyranosyloxypyrazole derivatives and medicinal use thereof |
| 06/29/2006 | US20060142203 Antiproliferative agents; angiogenese inhibitors; antiinflammatory agents; anticancer agents |
| 06/29/2006 | US20060142201 amino acid sequence containing Xaa1 Xaa2 Gly Val Cys Cys Gly Tyr Lys Leu Cys His Pro Cys SEQ ID NO. 3 where Xaa1 is a N-terminal pyroglutamate (pGlu) or D-pyroglutamate (DpGlu) residue; and Xaa2 is Asn or a deletion; prophylaxis; neuropathic pain, inflammation, incontinence, cardiovascular conditions |
| 06/29/2006 | US20060142200 Compounds and methods for lowering cholesterol levels without inducing hypertrigylceridemia |
| 06/29/2006 | US20060142195 Non-neurotoxic plasminogen activating factors for treating of stroke |
| 06/29/2006 | US20060141476 Growth arrest homeobox gene |
| 06/29/2006 | US20060141080 Extracting crushed plant material Cuminum cyminum with water or 50% aqueous alcoholic solvent; extracting a portion of the aqueous extract with n-butanol, separating -butanol layer and an aqueous layer, evaporating, and freeze drying the aqueous layer |
| 06/29/2006 | US20060141079 Supplement foods and pharmaceuticals |
| 06/29/2006 | US20060141070 Notoginseng saponin intravenous injection and the method for preparing this injection |
| 06/29/2006 | US20060140979 Antigenic polypeptides |
| 06/29/2006 | US20060140954 Novel human protein kinases and protein kinase-like enzymes |
| 06/29/2006 | US20060140937 B7-related nucleic acids and polypeptides useful for immunomodulation |
| 06/29/2006 | US20060140928 Use of heparinases to decrease inflammatory response |
| 06/29/2006 | DE102004061503A1 New meta-substituted thiazolidinone compounds are polo-like kinase inhibitors useful to treat cancers, autoimmune-, cardiovascular-, infectious-, nephrological-, nephrological- and neurodegenerative-diseases |
| 06/29/2006 | DE102004061288A1 New 3-amino-pyrazolo(3,4b)pyridine derivatives are protein tyrosine kinases inhibitors useful e.g. for treating hyperproliferation of body cells, neurodegenerative disease, blood vessel disease and angiogenic disease |
| 06/29/2006 | DE10038110B4 Pharmazeutische Zusammensetzungen Pharmaceutical compositions |
| 06/29/2006 | CA2592442A1 Pyridine compounds for the treatment of prostaglandin mediated diseases |
| 06/29/2006 | CA2592201A1 Neuromedin s and the use thereof |
| 06/29/2006 | CA2591304A1 Compositions and methods relating to anti-igf-1 receptor antibodies |
| 06/29/2006 | CA2589648A1 Fused pyrazole derivatives and methods of treatment of metabolic-relateddisorders thereof |
| 06/29/2006 | CA2589331A1 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin |
| 06/29/2006 | CA2588037A1 Indazole-carboxamide compounds |
| 06/29/2006 | CA2587664A1 Compounds with kv4 ion channel activity |
| 06/28/2006 | EP1674566A1 Method of promoting subsistence and/or proliferation of neural stem cell and promoting extension of neurite, promoter therefor, pharmaceutical composition containing neural stem cell, method of assay and method of screening |
| 06/28/2006 | EP1674456A2 Substituted alpha-halo-beta-keto-pyridinylpropanoates |
| 06/28/2006 | EP1674454A1 SUBSTITUTED 2-AMINO- 1,2,4 TRIAZOLO 1,5-a PYRIMIDINE DERIVATIVE AND USE THEREOF |
| 06/28/2006 | EP1674452A1 Novel 4-phenylamino-benzaldoxime derivative and use thereof as mek inhibitor |
| 06/28/2006 | EP1674109A1 Remedy for kidney diseases |
| 06/28/2006 | EP1674099A1 Therapeutic combination of amlodipine and benazepril / benazeprilat |
| 06/28/2006 | EP1674090A1 Early insulin secretion promoter |
| 06/28/2006 | EP1674089A1 Accelerator for initial insulin secretion |
| 06/28/2006 | EP1673384A2 Nitrosated glutamic acid compounds, compositions and methods of use |
| 06/28/2006 | EP1673353A1 Transition state structure and inhibitors of thymidine phosphorylases |
| 06/28/2006 | EP1673341A1 Tetrahydropyridine derivatives |
| 06/28/2006 | EP1673338A1 Fatty acid compounds, preparation and uses thereof |
| 06/28/2006 | EP1562920B1 Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines |
| 06/28/2006 | EP1544201B1 Novel derivatives of cycloalcanodiones, method for the production thereof and their pharmacological applications |
| 06/28/2006 | EP1355644B1 The use of substituted azetidinone compounds for the treatment of sitosterolemia |
| 06/28/2006 | EP1268783B1 Antiangiogene Eigenschaften von Matin und Fragmenten oder Varianten davon |
| 06/28/2006 | EP1267901B9 Compositions suitable for the treatment of damage caused by ischemia/reperfusion or oxidative stress |
| 06/28/2006 | EP1214452B1 Method for identifying novel genes involved in the regulation of angiogenesis, study of said genes and use thereof for therapeutic purposes |
| 06/28/2006 | EP1154767B9 Substituted stilbene compounds with vascular damaging activity |
| 06/28/2006 | EP1121372B1 Adenine derivatives |
| 06/28/2006 | EP1107762B9 Use of misoprostol or/and misoprostol acid for preparing drug in order to cure sexual dysfunction in women |
| 06/28/2006 | EP1062237B1 Ribonucleotide polypeptides containing metal |
| 06/28/2006 | EP0675732B1 Use of relaxin in the manufacture of therapeutic agents |
| 06/28/2006 | CN1795195A Pyridopyrazines and the use thereof as kinase inhibitors |
| 06/28/2006 | CN1795180A Novel quinazoline derivatives and methods of treatment related to the use thereof |
| 06/28/2006 | CN1795163A Carboxylic compound and medicine comprising the same |
| 06/28/2006 | CN1795007A Methods and compositions for the treatment of gastrointestinal disorders |
| 06/28/2006 | CN1794993A Medicinal composition containing benidipine hydrochloride |
| 06/28/2006 | CN1793379A Blood vessel growth hormone gene recombined gland relative vrius carrier and its preparation process and application thereof |
| 06/28/2006 | CN1793156A Luteolin-7-O-bata-glucuronide and its extracting process and application thereof |
| 06/28/2006 | CN1793146A Process for the production of 9-pyro-3, 7-biazobicyclononane(3.3.1) |
| 06/28/2006 | CN1793134A Process for separating purifying actived tea polyphenols |
| 06/28/2006 | CN1793132A Derivative of cyclo membranousol kind and application thereof |
| 06/28/2006 | CN1793104A Process for extracting high purity alpha-linolenic acid from pepper category and medicine application thereof |
| 06/28/2006 | CN1792369A Shuguan extractive for treating coronary heart disease, and its oral preparation |
| 06/28/2006 | CN1792366A Ginkgo leaves dispersion tablets, and its preparing method |
| 06/28/2006 | CN1792229A Green health-care porridge |
| 06/28/2006 | CN1261592C Antigen polypeptide of IC53 gene product, use of auto-body in diagnosis and treating of arrhythmia cardimyopathy and reagent kit containing the polypeptide |
| 06/28/2006 | CN1261570C Actinia neurotoxin gene and its application |
| 06/28/2006 | CN1261453C Platelet-derived growth factor D, DNA coding and uses thereof |
| 06/28/2006 | CN1261433C 1,3,8-triaza-spiro[4,5]decan-4-one derivs. as neurokinin receptor antagonists |
| 06/28/2006 | CN1261431C 2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof |
| 06/28/2006 | CN1261429C Cholesterol lowering benzo [b] thiophenes and benzo[d] isothiazoles |
| 06/28/2006 | CN1261165C Preparation for prophylaxis of restenosis |
| 06/28/2006 | CN1261155C Medication of Chinese traditional medicine for treating ischemia in blood vessel of heart and brain |
| 06/28/2006 | CN1261148C Medication for curing cardiovascular disease and preparation method |
| 06/28/2006 | CN1261139C Medicine for treating bone tuberculosis, osteomyelitis, synovitis and angiitis |
| 06/28/2006 | CN1261118C Medicine for treating arteriosclerosis and coronary heart disease and its preparation method |
| 06/28/2006 | CN1261098C p38-alpha kinase inhibitors |
| 06/28/2006 | CN1261097C Nisoldipine capsule composition |
| 06/27/2006 | US7067713 C1 Inhibitor produced in the milk of transgenic non-human mammals |
| 06/27/2006 | US7067694 Halogen-substituted amino dicarboxylic acid derivatives as medicaments for treating cardiovascular diseases |
| 06/27/2006 | US7067667 Aminoalkyl-3, 4-dihydroquinoline derivatives as no-synthase inhibitors |
| 06/27/2006 | US7067665 phenylethoxy-phenyl- or -pyridyl- (acet) amides, N-substituted with pyrimidine ring-containing (tetrahydro)pyridines or phenyl groups; e.g., 3-[2-(2,4-Dichloro-phenyl)-ethoxy]-4-methoxy-N-[4-(pyrimidin-2-ylsulfamoyl)-phenyl]-benzamide; treating cardiovascular disorders such as thromboses and restenoses |
| 06/27/2006 | US7067649 Includes an endothelial specific enhancer element; especially modifications of the PPE promoter, which enhance its expression in response to hypoxia and angiogenesis. |